Lipocine Inc. (LPCN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
5:00 pm
Purchase
2026-03-3113GLIPOCINE INC INC
LPCN
Ikarian Capital, LLC508,556
6.300%
508,556increase
(New Position)
Filing
History
2026-05-15
11:55 am
Sale
2026-03-3113GLIPOCINE INC INC
LPCN
Squadron Master Fund LP450,000
6.200%
-80,000decrease
(-15.09%)
Filing
History
2026-02-17
11:49 am
Purchase
2025-12-3113GLIPOCINE INC INC
LPCN
Squadron Master Fund LP530,000
9.500%
30,000increase
(+6.00%)
Filing
History
2025-12-23
3:49 pm
Purchase
2025-12-1813GLIPOCINE INC INC
LPCN
Squadron Master Fund LP500,000
9.000%
500,000increase
(New Position)
Filing
History
2022-02-10
08:22 am
Purchase
2021-12-3113GLIPOCINE INC
LPCN
VANGUARD GROUP INC224,116
4.320%
12,880increase
(+6.10%)
Filing
History